返回 Agenda
SLS04 Scientific Benefit-Risk Management and Communication for the Future
Session Chair(s)
Mamoru Narukawa, PHD, RPH
Professor
Kitasato University, Japan
Speaker(s)
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Juan Garcia-Burgos, MD, PHD
European Medicines Agency, Netherlands
Head of Public and Stakeholders Engagement Department
Kazuhiko Ishida, MSC, RPH
Astellas Pharma Inc., Japan
Director, Pharmacovigilance